Picture of Bioxytran logo

BIXT Bioxytran Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Bioxytran, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash
Cash and Short Term Investments0.0150.0360.170.0420.072
Net Total Accounts Receivable
Net Total Receivables0.0230.05
Total Inventory
Prepaid Expenses
Total Current Assets0.0430.0360.220.3160.072
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.682
Net Intangible Assets
Total Assets0.7260.0360.220.3260.119
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities0.1830.2621.022.273.28
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities0.1830.2621.023.162.88
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity0.542-0.225-0.799-2.83-2.76
Total Liabilities & Shareholders' Equity0.7260.0360.220.3260.119
Total Common Shares Outstanding
Total Preferred Shares Outstanding

Or unlock with your email

Or unlock with your email